Cormorant Global Healthcare Master Fund, LP
CIK 1618442 · last filed 2025-08-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$300.14M
Companies
10
Total Filings
14
Lifetime Open-Market Net
$440.85M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BMEA | 10%+ Owner | 3,570,872 | $1.25 | $4.46M | $48.00M | 3 | 2025-08-01 |
| CRBP | 10%+ Owner | 2,349,231 | $9.09 | $21.34M | $21.01M | 1 | 2024-09-24 |
| EYPT | 10%+ Owner | 7,288,479 | $11.96 | $87.17M | $31.47M | 1 | 2024-04-22 |
| Ambrx Biopharma, Inc. (AMAM) Delisted | 10%+ Owner | 11,231,000 | $28.00 | $314.47M | $137.84M | 2 | 2023-10-25 |
| MLTX | 10%+ Owner | 8,367,498 | $18.71 | $156.56M | $100.80M | 1 | 2023-10-04 |
| Vigil Neuroscience, Inc. (VIGL) Delisted | 616,786 | $8.05 | $4.97M | $0 | 1 | 2022-01-13 | |
| TYRA | 757,432 | $30.88 | $23.39M | $20.00M | 1 | 2021-09-21 | |
| IMRX | 10%+ Owner | 1,702,628 | $4.24 | $7.22M | $33.00M | 1 | 2021-08-05 |
| Prometheus Biosciences, Inc. (RXDX) Delisted | 2,223,022 | $199.92 | $444.43M | $28.50M | 1 | 2021-03-18 | |
| KINETA, INC./DE (PTI) Delisted | 10%+ Owner | 180,017 | — | — | $20.24M | 2 | 2016-12-06 |
Recent Filings · Page 2 of 2
14 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-08-05 | IMRX | Mixed | +9,010,512 | $33.00M | EDGAR |
| 2021-03-18 | Prometheus Biosciences, Inc. (RXDX) Delisted | Mixed | +8,892,088 | $28.50M | EDGAR |
| 2016-12-06 | KINETA, INC./DE (PTI) Delisted | Buy (P) | +351,892 | $3.74M | EDGAR |
| 2016-11-23 | KINETA, INC./DE (PTI) Delisted | Buy (P) | +1,447,452 | $16.50M | EDGAR |
Showing 11–14 of 14
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.